|

Osilodrostat 1 MG Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Mayo Clinic1

Indications

  • Autonomous Cortisol Secretion (ACS)1
  • Mild Autonomous Cortisol Secretion1
  • Cancer1

Rochester, Minnesota1 trial

Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)

Mayo Clinic

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.